07:00 , May 2, 2013 |  BC Innovations  |  Distillery Therapeutics

Indication: Neurology

This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Neurology Alzheimer's disease (AD) AMP-activated protein kinase (AMPK); b-amyloid 42 (Ab42); calcium calmodulin-dependent protein kinase kinase 2 (CAMKK2) Mouse and cell culture...